Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed Aug 5, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0001104659-26-090835)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-08-05

Form type: SCHEDULE 13G
Filing date: Aug 5, 2026
Accession number: 0001104659-26-090835
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)